Identification and treatment of chemoresistant inoperable or metastatic GIST: experience with the selective tyrosine kinase inhibitor imatinib mesylate (STI571)
- 1 September 2002
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 38, S52-S59
- https://doi.org/10.1016/s0959-8049(02)80603-7
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Diagnosis of gastrointestinal stromal tumors: A consensus approachHuman Pathology, 2002
- STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implicationsOncogene, 2001
- The histopathological differential diagnosis of gastrointestinal stromal tumoursJournal of Clinical Pathology, 2001
- Gastrointestinal stromal tumors - definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosisVirchows Archiv, 2001
- KIT Extracellular and Kinase Domain Mutations in Gastrointestinal Stromal TumorsThe American Journal of Pathology, 2000
- Two Hundred Gastrointestinal Stromal TumorsAnnals of Surgery, 2000
- Interstitial Cells of Cajal as Precursors of Gastrointestinal Stromal TumorsThe American Journal of Surgical Pathology, 1999
- Familial gastrointestinal stromal tumours with germline mutation of the KIT geneNature Genetics, 1998
- Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal TumorsScience, 1998
- Developmental origin andkit-dependent development of the interstitial cells of cajal in the mammalian small intestineDevelopmental Dynamics, 1998